Rutaecarpine
Rutaecarpine has been studied in 1 paper since 2024: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Apr 4, 2024: “Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells”.
- 1 lab in 1 country
- Cells1
What did studies of Rutaecarpine find?
2Studies of Rutaecarpine measured 2 outcomes; the most studied are bone volume (1 study) and osteoblast differentiation (1).
Bone volume
upin chickens1
1 study
Bone volume
upin chickens1
Rutaecarpine increases bone volume in chickens.
“Ex-vivo treatment with Apigenin and Rutaecarpine of organotypic embryonic chick-femur culture significantly increased bone volume and cortical thickness”
Animalsorganotypic embryonic chick-femur culturefemur
Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells
Frontiers in endocrinology
Osteoblast differentiation
upin human cells1
1 study
Osteoblast differentiation
upin human cells1
Rutaecarpine increases osteoblast differentiation in human cells.
“In vitro treatment with Apigenin and Rutaecarpine, of primary hBMSCs obtained from elderly female patients enhanced osteoblast differentiation”
Cellsprimary hBMSCs obtained from elderly female patientsbone marrow stromal stem cells
Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells
Frontiers in endocrinology